Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study

Published:2022-01-05 Issue: Volume: Page:
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Innes Hamish¹²³^ORCID,McDonald Scott A.¹²^ORCID,Hamill Victoria¹²,Yeung Alan¹²,Dillon John F.⁴^ORCID,Hayes Peter C.⁵,Went April²,Fraser Andrew⁶⁷,Bathgate Andrew⁵,Barclay Stephen T.⁸,Janjua Naveed⁹¹⁰,Goldberg David J.¹²,Hutchinson Sharon J.¹²

Affiliation:

1. School of Health and Life Sciences Glasgow Caledonian University Glasgow UK

2. Public Health Scotland Glasgow UK

3. Division of Epidemiology and Public Health University of Nottingham Nottingham UK

4. Division of Molecular and Clinical Medicine School of Medicine University of Dundee Dundee UK

5. Royal Infirmary of Edinburgh Edinburgh UK

6. Aberdeen Royal Infirmary Aberdeen UK

7. Queen Elizabeth University Hospital Glasgow UK

8. Glasgow Royal Infirmary Glasgow UK

9. British Columbia Centre for Disease Control Vancouver BC Canada

10. School of Population and Public Health Faculty of Medicine University of British Columbia Vancouver BC Canada

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15143

Reference25 articles.

1. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach JK;Hepatology,2018

2. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection

3. The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen

4. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

5. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

2. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions;The Lancet Gastroenterology & Hepatology;2024-04

3. Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019);World Journal of Virology;2024-03-25

4. Effect of previous infection with hepatitis B virus on the incidence of hepatocellular carcinoma after sustained virologic response in patients with chronic hepatitis C virus infection;Journal of Viral Hepatitis;2023-12-26

5. Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study;BMJ Open Gastroenterology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3